Pharmaceutical - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

176 to 200 of 647 results

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system

29-10-2013

The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…

Asia-PacificGenericsPharmaceuticalPricing

Roche and Chugai’s SC RoActemra improves RA long term

Roche and Chugai’s SC RoActemra improves RA long term

28-10-2013

Roche and its majority-owned Japanese subsidiary Chugai Pharmaceutical have announced that their RoActemra…

Anti-Arthritics/RheumaticsAsia-PacificChugai PharmaceuticalPharmaceuticalResearchRoActemraRoche

First ever flu vaccine developed by Chinese researchers

28-10-2013

Chinese researchers have successfully developed the vaccine for the H7N9 bird flu virus, after the flu…

Anti-viralsAsia-PacificPharmaceuticalResearchTianyuan Bio-Pharmaceutical

DC AIDS protesters join push to demand China gives $1 billion to fight global AIDS

25-10-2013

The Washington DC, USA based AIDS Healthcare Foundation (AHF) is spearheading a series of US and global…

Anti-viralsAsia-PacificFinancialPharmaceuticalPolitics

Imugene to acquire Biolife Sciences

24-10-2013

Australian drug development and pharmaceutical company Imugene says it has executed a sale and purchase…

Asia-PacificMergers & AcquisitionsOncologyPharmaceutical

Medivation and Astellas reveal positive Phase III results for prostate cancer drug

Medivation and Astellas reveal positive Phase III results for prostate cancer drug

23-10-2013

Medivation and Japanese drug major Astellas Pharma have announced positive results from the Phase III…

Asia-PacificAstellas PharmaenzalutamideMedivationOncologyPharmaceuticalResearchXtandi

Japan’s drug pricing authority starts debates on institutionalization of premium system

Japan’s drug pricing authority starts debates on institutionalization of premium system

21-10-2013

It was three weeks ago when the Central Social Insurance Medical Council (CSIMC) held a meeting and listened…

Asia-PacificPharmaceuticalPoliticsPricing

AstraZeneca enters “open innovation” research accord with Taiwan’s NRPB

AstraZeneca enters “open innovation” research accord with Taiwan’s NRPB

18-10-2013

Anglo-Swedish drug major AstraZeneca has linked with Taiwan’s National Research Program for Biopharmaceuticals…

Asia-PacificAstraZenecaPharmaceuticalResearch

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

18-10-2013

Ablynx has granted an exclusive license to Eddingpharm to develop and commercialize its anti-RANKL Nanobody,…

AblynxAsia-PacificEddingpharmLicensingPharmaceuticalWomen's Health

Zydus in deal with Pieris for novel Anticalin therapeutics

16-10-2013

Indian drugmaker Zydus Cadila has entered into an alliance with privately-held German company Pieris…

Asia-PacificLicensingOncologyPharmaceuticalPieris AGPRS-110Zydus Cadila

Wockhardt hit hard by MHRA’s withdrawal of certificate

Wockhardt hit hard by MHRA’s withdrawal of certificate

15-10-2013

Indian drugmaker Wockhardt has had its Good Manufacturing Practice certificate revoked by the UK’s…

Asia-PacificPharmaceuticalProductionRegulationWockhardt

Ono sets up subsidiary in South Korea

14-10-2013

Japanese drugmaker Ono Pharmaceutical has decided to establish a new fully owned subsidiary in South…

Asia-PacificManagementMarkets & MarketingPharmaceutical

AstraZeneca to co-promote Janssen prostate cancer drug in Japan

AstraZeneca to co-promote Janssen prostate cancer drug in Japan

11-10-2013

Anglo-Swedish drug major AstraZeneca has entered into an agreement with US health care giant Johnson…

abirateroneAsia-PacificAstraZenecaJanssenJohnson & JohnsonLicensingMarkets & MarketingOncologyPharmaceuticalZytiga

Lilly acquires rights to Hutchison MediPharma cancer drug candidate

Lilly acquires rights to Hutchison MediPharma cancer drug candidate

09-10-2013

Hutchison MediPharma, an R&D company majority owned by China’s Chi-Med, has entered into a licensing,…

Asia-PacificEli LillyfruquintinibHutchison MediPharmaLicensingOncologyPharmaceutical

“Don’t import NZ medicines system,” warns Medicines Australia

09-10-2013

Speaking at a Medicines New Zealand conference in Auckland today (October 9), pharma trade group Medicines…

Asia-PacificFinancialHealthcarePharmaceutical

EU and Japan improve information-sharing using EudraGMDP database

EU and Japan improve information-sharing using EudraGMDP database

08-10-2013

Information will be shared between Japan and the European Union about good practice compliance relating…

Asia-PacificEuropePharmaceuticalRegulation

Medicines Australia questions spending on medicines

08-10-2013

Australians are seeing their access to new medicines on the Pharmaceutical Benefits Scheme delayed while…

Asia-PacificFinancialHealthcarePharmaceuticalPolitics

Asia-Pacific solid tumors market to reach $2.3 billion by 2019

08-10-2013

The Asia-Pacific solid tumors treatment markets - bladder, ovarian, pancreatic and prostate cancers -…

Asia-PacificMarkets & MarketingOncologyPharmaceuticalPricing

Japanese lawmakers are stepping in to Diovan investigation

07-10-2013

Members of Japan’s Diet (Congressmen) have formed a bipartisan study group to examine Swiss drug major…

Asia-PacificCardio-vascularDiovanNovartisPharmaceuticalPoliticsRegulationResearch

Debiopharm collaborates with A*STAR’s ETC on oncology targets

07-10-2013

Swiss independent drug developer Debiopharm has signed an exclusive research collaboration with the Singapore-based…

A*STARAsia-PacificDebiopharmOncologyPharmaceuticalResearch

PeptiDream and Ipsen expand their peptide drug collaboration to treat endocrinologic disease

07-10-2013

PeptiDream and Ipsen have expanded the scope of their April 2013 research collaboration and license option…

Asia-PacificGastro-intestinalsIpsenLicensingPeptiDreamPharmaceutical

Takeda partners with newly-formed Tri-1 TDI

Takeda partners with newly-formed Tri-1 TDI

07-10-2013

The USA’s Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical…

Asia-PacificFinancialNorth AmericaPharmaceuticalResearchTakeda Pharmaceuticals

Hutchison China MediTech well placed to tap opportunities in China, say analysts

07-10-2013

Favorable demand trends, coupled with the supportive environment for clinical research, mean the prospects…

Asia-PacificFinancialHutchison MediPharmaHutchison MediTechPharmaceuticalResearch

Indian pharmaceutical market to reach $56 billion by 2020, says GlobalData

03-10-2013

Driven by the country’s growing economy and population income, the Indian pharmaceutical market will…

Asia-PacificMarkets & MarketingPatentsPharmaceuticalRegulation

176 to 200 of 647 results

Back to top